Corpus Intelligence IC Memo — TRIANGLE SPRINGS 2026-04-26 06:39 UTC
IC Memo — TRIANGLE SPRINGS
Investment Committee Memorandum | NC | 77 beds | Grade C | EBITDA uplift $1.8M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

TRIANGLE SPRINGS

CCN 344032 | WAKE, NC | 77 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

TRIANGLE SPRINGS is a 77-bed suburban community hospital in WAKE, NC with $24.2M in net patient revenue and a -3.7% operating margin. The hospital serves a payer mix of 12.2% Medicare, 0.1% Medicaid, and 87.7% commercial.

Thesis: Turnaround. Our ML models identify $1.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -3.7% to 3.7% (+736bps).

Net Revenue HCRIS$24.2M
Current EBITDA COMPUTED$-892K
Operating Margin COMPUTED-3.7%
Occupancy HCRIS85.2%
Revenue / Bed COMPUTED$314K
Net-to-Gross HCRIS30.1%
Distress Probability ML39.7%

2. Market Context & Competitive Position

129
NC Hospitals
-2.0%
State Median Margin
51
Comparable Hospitals

NC has 129 Medicare-certified hospitals with a median operating margin of -2.0%. The target's margin of -3.7% places it below the state median. Among 51 size-comparable peers (38-154 beds), the median margin is -1.7%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (38-154), prioritizing same-state peers. 51 hospitals in the comp set.

HospitalStateBedsRevenueMargin
TRIANGLE SPRINGS (Target)NC77$24.2M-3.7%
ATRIUM HEALTH UNIVERSITY CITYNC104$286.9M28.6%
PRESBYTERIAN HOSPITAL HUNTERSVNC135$276.7M21.8%
ADVENTHEALTH HENDERSONVILLENC73$227.1M-4.1%
THOMASVILLE MEDICAL CENTERNC73$220.3M-14.3%
SCOTLAND MEMORIAL HOSPITALNC104$198.0M-2.8%
WATAUGA MEDICAL CENTERNC95$187.3M2.4%
CARTERET COUNTY GENERAL HOSPITNC99$187.2M6.4%
CALDWELL MEMORIAL HOSPITALNC137$166.2M-1.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.8M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$508K+210bp18mo
Cost to Collect4.5%2.5%$484K+200bp12mo
Denial Rate Reduction12.0%6.5%$479K+198bp12mo
A/R Days Reduction5200.0%3800.0%$294K+122bp9mo
Clean Claim Rate88.0%96.0%$15K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$508K
Cost to Collect
$484K
Denial Rate Reduction
$479K
A/R Days Reduction
$294K
Clean Claim Rate
$15K
Total EBITDA Uplift$1.8M
Current EBITDA$-892K
+ RCM Uplift+$1.8M
Pro Forma EBITDA$889K
Current Margin-3.7%
Pro Forma Margin3.7%
WC Released (1x)$928K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-1.4M$11.9M0.00x-100.0%
Base (11x exit)10.0x11.0x$-1.4M$12.7M0.00x-100.0%
Bull Case9.0x11.0x$-1.2M$18.1M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-1.2M$19.4M0.00x-100.0%
Bear Case11.0x10.0x$-1.5M$3.5M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-1.5M$3.3M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 51 hospitals with 38-154 beds
  • Same-state prioritization (n=52)
  • Comp margins: P25=-8.9% / P50=-1.7% / P75=12.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.